Pinnacle West Capital Corporation (PNW) Q4 2025 Earnings Call Transcript
Summarize this article with:
SA Transcripts158.61K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Pinnacle West Capital Corporation (PNW) Q4 2025 Earnings Call February 25, 2026 11:00 AM EST Company Participants Amanda Ho - Director of Investor RelationsTheodore Geisler - Chairman of the Board, President and CEOAndrew Cooper - Senior VP & CFO Conference Call Participants Fei She - Barclays Bank PLC, Research DivisionAlexander Calvert - Wells Fargo Securities, LLC, Research DivisionJulien Dumoulin-Smith - Jefferies LLC, Research DivisionPaul Patterson - Glenrock Associates LLCStephen D’Ambrisi - RBC Capital Markets, Research DivisionRyan Levine - Citigroup Inc., Research DivisionAnthony Crowdell - Mizuho Securities USA LLC, Research DivisionChristopher Ellinghaus - Siebert Williams Shank & Co., L.L.C., Research Division Presentation Operator Good day, everyone, and welcome to the Pinnacle West Capital Corporation 2025 Fourth Quarter Earnings Conference Call. [Operator Instructions] It is now my pleasure to hand the floor over to your host, Amanda Ho. Ma'am, the floor is yours. Amanda HoDirector of Investor Relations Thank you, Matthew. I would like to thank everyone for participating in this conference call and webcast to review our fourth quarter and full year 2025 Earnings, Recent Developments and Operating Performance. Our speakers today will be our Chairman, President and CEO, Ted Geisler; and our CFO, Andrew Cooper. Jacob Tetlow, COO; and Jose Esparza SVP of Public Policy, are also here with us. First, I need to cover a few details with you. The slides that we will be using are available on our Investor Relations website, along with our earnings release and related information. Today's comments and our slides contain forward-looking statements based on current expectations, and actual results may differ materially from expectations. Our annual 2025 Form 10-K was filed this morning. Please refer to that document for forward-looking statements cautionary language as well as the risk factors and MD&A sections, which identify risks and uncertainties that could cause actual results to